Author： Smalley Keiran S. M. Weber Jeffrey S.
Publisher： Oxford University Press
ISSN： 1460-2105
Source： Journal of the National Cancer Institute, Vol.105, Iss.9, 2013-05, pp. : 591-592
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
P21-Activated Kinase 1 (PAK1) as a Therapeutic Target in BRAF Wild-Type Melanoma
By Ong Christy C. Jubb Adrian M. Jakubiak Diana Zhou Wei Rudolph Joachim Haverty Peter M. Kowanetz Marcin Yan Yibing Tremayne Jarrod Lisle Richard Harris Adrian L. Friedman Lori S. Belvin Marcia Middleton Mark R. Blackwood Elizabeth M. Koeppen Hartmut Hoeflich Klaus P.
Journal of the National Cancer Institute, Vol. 105, Iss. 9, 2013-05 ,pp. :
Access to resources
Recommend
BRAF mutations in chronic lymphocytic leukemia
By Jebaraj Billy Michael Chelliah
Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. :
Endocrinology of the wild and mutant BRCA1 gene and types of hormonal carcinogenesis
Future Oncology, Vol. 4, Iss. 1, 2008-02 ,pp. :
By Galimberti Fabrizio Busch Alexander M. Chinyengetere Fadzai Ma Tian Sekula David Memoli Vincent A. Dragnev Konstantin H. Liu Fang Johnson Kevin C. Guo Yongli Freemantle Sarah J. Andrew Angeline S. Greninger Patricia Robbins David J. Settleman Jeff Benes Cyril Dmitrovsky Ethan
International Journal of Oncology, Vol. 41, Iss. 5, 2012-11 ,pp. :